100 related articles for article (PubMed ID: 20216329)
1. Anti-TNF-associated palmoplantar pustulosis.
Pyrpasopoulou A; Chatzimichailidou S; Simoulidou E; Aslanidis S
J Clin Rheumatol; 2010 Apr; 16(3):138-9. PubMed ID: 20216329
[No Abstract] [Full Text] [Related]
2. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
3. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
[No Abstract] [Full Text] [Related]
4. Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis.
Alabed IB; Qushmaq KA; Khan MA
Saudi Med J; 2010 Sep; 31(9):1054-6. PubMed ID: 20844821
[TBL] [Abstract][Full Text] [Related]
5. Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers.
Lo Nigro A; Ramonda R; Alaibac M; Modesti V; Punzi L
Eur J Dermatol; 2011; 21(2):263-4. PubMed ID: 21411412
[No Abstract] [Full Text] [Related]
6. Cutaneous granulomas during infliximab therapy for spondyloarthropathy.
Dubosc AE; Perroud AM; Bagot M; Farenq V; Chevalier X; Maitre B; Claudepierre P
J Rheumatol; 2008 Jun; 35(6):1222-3. PubMed ID: 18412298
[No Abstract] [Full Text] [Related]
7. A case of infliximab-induced psoriasis.
Richetta A; Mattozzi C; Carlomagno V; Maiani E; Carboni V; Giancristoforo S; D'Epiro S; Bruni F; Calvieri S
Dermatol Online J; 2008 Nov; 14(11):9. PubMed ID: 19094847
[TBL] [Abstract][Full Text] [Related]
8. Asthenoazoospermia in patients receiving anti-tumour necrosis factor {alpha} agents.
Montagna GL; Malesci D; Buono R; Valentini G
Ann Rheum Dis; 2005 Nov; 64(11):1667. PubMed ID: 16227427
[No Abstract] [Full Text] [Related]
9. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
Roux CH; Brocq O; Leccia N; Giacchero D; Breuil V; Albert C; Lacour J; Perrin C; Euller-Ziegler L
J Rheumatol; 2007 Feb; 34(2):434-7. PubMed ID: 17295430
[TBL] [Abstract][Full Text] [Related]
10. [Anti-TNF alfa therapy in ankylosing spondylitis].
Cravo AR; Tavares V; Da Silva JC
Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716
[TBL] [Abstract][Full Text] [Related]
11. Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis.
Marakli SS; Uzun S; Ozbek S; Tuncer I
Eur J Dermatol; 2008; 18(1):88-9. PubMed ID: 18086603
[No Abstract] [Full Text] [Related]
12. Palmoplantar pustular psoriasis induced by adalimumab: a case report and literature review.
Ibis N; Hocaoglu S; Cebicci MA; Sutbeyaz ST; Calis HT
Immunotherapy; 2015; 7(7):717-20. PubMed ID: 26250408
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis induced by anti-TNF probably not so uncommon.
Bosch RI; Amo Ndel V; Manteca CF; Cortina EL; Polo RG; Courel LG
J Clin Rheumatol; 2008 Apr; 14(2):128; author reply 130. PubMed ID: 18391691
[No Abstract] [Full Text] [Related]
14. Uveitis and tumour necrosis factor blockade in ankylosing spondylitis.
Coates LC; McGonagle DG; Bennett AN; Emery P; Marzo-Ortega H
Ann Rheum Dis; 2008 May; 67(5):729-30. PubMed ID: 18408116
[No Abstract] [Full Text] [Related]
15. Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct?
Michaëlsson G; Kajermo U; Michaëlsson A; Hagforsen E
Br J Dermatol; 2005 Dec; 153(6):1243-4. PubMed ID: 16307676
[No Abstract] [Full Text] [Related]
16. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
[TBL] [Abstract][Full Text] [Related]
17. Erythema multiforme with tumour necrosis factor inhibitors: a class effect?
Kain T; MacGregor D; Buchanan RR; de Jager JP; Schachna L
Ann Rheum Dis; 2008 Jun; 67(6):899-900. PubMed ID: 18474663
[No Abstract] [Full Text] [Related]
18. Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis.
Safa G; Martin A; Darrieux L
J Clin Rheumatol; 2011 Oct; 17(7):385-6. PubMed ID: 21946468
[No Abstract] [Full Text] [Related]
19. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
Keat A; Barkham N; Bhalla A; Gaffney K; Marzo-Ortega H; Paul S; Rogers F; Somerville M; Sturrock R; Wordsworth P;
Rheumatology (Oxford); 2005 Jul; 44(7):939-47. PubMed ID: 15901904
[No Abstract] [Full Text] [Related]
20. The anti-TNF revolution in ankylosing spondylitis: patients with severe disease now have access to promising new drugs.
Schachna L
Med J Aust; 2004 Nov; 181(10):529-30. PubMed ID: 15540959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
